Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1

Blood

Volumn 92, Issue 1, 1998, Pages 267-272

  Side, Lucy E ^b   Emanuel, Peter D ^b   Taylor, Brigit ^b   Franklin, Janet ^b   Thompson, Patricia ^b   Castleberry, Robert P ^b   Shannon, Kevin M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATE; NEUROFIBROMIN; RAS PROTEIN;

ALLELE; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; INFANT; MALE; MYELODYSPLASTIC SYNDROME; MYELOMONOCYTIC LEUKEMIA; NEUROFIBROMATOSIS; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0032125716     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.1.267.413a31_267_272     Document Type: Article

References (53)

1. Luna-Fineman S, Shannon K, Lange BJ: Childhood monosomy 7: Epidemiology, biology and mechanistic implications. Blood 85:1985, 1995
2. Bader-Meunier B, Mielot F, Tchernia G, Buisine J, Delsol G, Duchayne E, Lemerle S, Leverger G, de Lumley L, Manel A-M, Nathanson M, Plantaz D, Robert A, Schaison G, Sommelet D, Vilmer E: Myelodysplastic syndromes in childhood: Report of 49 patients from a French multicentre study. Br J Haematol 92:344, 1996
3. Passmore SJ, Hann IM, Stiller CA, Ramani P, Swansbury GJ, Gibbons B, Reeves B, Chessells J: Pediatric myelodysplasia: A study of 68 children and anew prognostic scoring system. Blood 85:1743, 1995
4. Arico M, Biondi A, Pui C-H: Juvenile myelomonocytic leukemia. Blood 90:479, 1997
5. Gadner H, Haas OA: Experience in pediatric myelodysplastic syndromes. Hematol Oncol Clin North Am 6:655, 1992
6. Emanuel PD, Shannon KM, Castleberry RP: Juvenile myelomonocytic leukemia: Molecular understanding and prospects for therapy. Mol Med Today 2:468475, 1996
7. Niemeyer C, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, Haas O, Harbott J, Hasle H, Kerndrup G, Locatelli F, Mann G, Stollmann-Gibbels B, van't Veer-Korthof ETh, van Wering E, Zimmermann M: Chronic myelomonocytic leukemia in childhood: A retrospective analysis of 110 cases. Blood 89:3534, 1997
8. Riccardi VM, Eichner JE: Neurofibromatosis. Baltimore, MD, Johns Hopkins University, 1986
9. Stiller CA, Chessells JM, Fitchett M: Neurofibromatosis and childhood leukemia/lymphoma: A population-based UKCCSG study. Br J Cancer 70:969, 1994
10. Caitro-Malaspina H, Schaison G, Passe S, Pasquier A, Berger R, Bayle-Weisgerber C, Miller D, Seligmann M, Bernard J: Subacute and chronic myelomonocytic leukemia in children (Juvenile CML). Cancer 54:675, 1984
11. Shannon KM, Watterson J, Johnson P, O'Connell P, Lange B, Shah N, Kan YW, Priest JR: Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: Epidemiology and molecular analysis. Blood 79:1311, 1992
12. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F: The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63:851, 1990
13. Xu G, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, Weiss R: The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599, 1990
14. Bollag G, Clapp DW, Shih S, Adler F, Zhang Y, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K: Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in murine and human hematopoietic cells. Nat Genet 12:144, 1996
15. Jacks T, Shih S, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumorigenic and developmental consequences of a targeted Nf1 mutation in the mouse. Nat Genet 7:353, 1994
16. Largaespada DA, Brannan CI, Jenkins NA, Copeland NG: Nf1 deficiency causes Ras-mediated granulocyte-macrophage colony stimulating factor hypersensitivity and chronic myeloid leukemia. Nat Genet 12:137, 1996
17. Side L, Taylor B, Cayouette M, Connor E, Thompson P, Luce M, Shannon KM: Homozygous inactivation of NF1 in the bone marrows of children with neurofibromatosis, type 1 and malignant myeloid disorders. N Engl J Med 336:1713, 1997
18. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F: Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597, 1994
19. ras. Blood 84:3435, 1994
20. Gutmann D, Aylsworth A, Carey J, Korf B, Marks J, Pyeritz R, Rubenstein A, Viskochil D: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51, 1997
21. Carey JC, Lant JM, Hall BD: Penetrance and variability in neurofibromatosis: A genetic study of 60 families. Birth Defects 15:271, 1979
22. Riccardi VM: Genotype, malleotype, phenotype and randomness: Lessons from neurofibromatosis-1 (NF-1). Am J Hum Genet 53:301, 1993
23. Easton D, Ponder M, Huson S, Ponder B: An analysis of variation in expression of neurofibromatosis type 1 (NF1): Evidence for modifying genes. Am J Hum Genet 53:305, 1993
24. Li Y, O'Connell P, Breidenbach HH, Cawthon R, Stevens J, Xu G, Neil S, Robertson M, White R, Viskochil D: Genomic organisation of the neurofibromatosis 1 gene (NF1). Genomics 25:1, 1995
25. Carey J, Baty B, Johnson J, Morrion T, Skolnick M, Kivlin J: The genetic aspects of neurofibromatosis. Ann NY Acad Sci 486:45, 1986
26. Miles DK, Freedman MH, Stephens K, Pallavicini M, Sievers E, Weaver M, Grunberger T, Thompson P, Shannon KM: Patterns of hematopoietic lineage involvement in children with neurofibromatosis, type 1, and malignant myeloid disorders. Blood 88:4314, 1996
27. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning. A Laboratory Manual. New York, NY, Cold Spring Harbor Laboratory, 1989
28. Heim R, Kam-Morgan L, Binnie C, Corns D, Cayouette M, Farber R, Aylsworth A, Silverman L, Luce M: Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 4:975, 1995
29. Binnie CG, Kam-Morgan LNW, Cayouette M, Marra G, Boland CR, Luce MC: Rapid identification of RT-PCR clones containing translation-termination mutations. Mutat Res 388:21, 1997
30. Purandare SM, Breidenbach H, Li Y, Zhu XL, Sawada S, Neil SM, Brothman A, White R, Cawthon R, Viskochil D: Identification of neurofibromatosis type l (NF1) homologous loci by direct sequencing, fluorescence in situ hybridization, and PCR amplification of somatic cell hybrids. Genomics 30:476, 1995
31. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T: Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5:1037, 1990
32. Freedman MH, Estrov Z, Chan HSL: Juvenile chronic myelogenous leukemia. Am J Pediatr Hematol Oncol 10:261, 1988
33. Najfeld V, Vlachos A, Parker R, Burnett W, Scalise A, Fructman S: Evidence for the embryonic origin of partial chromosome 7 deletion in monozygotic twins with juvenile chronic myelogenous leukemia. Leukemia 11:306, 1997
34. Chessells JM: Myelodysplasia. Baillieres Clin Haematol 4:459, 1991
35. Xu G, Nelson L, O'Connell P, White R: An Alu polymorphism intragenic to the neurofibromatosis, type 1 gene. Nucleic Acids Res 19:3764, 1991
36. Andersen LB, Tarle SA, Marchuk DA, Legius E, Collins FS: A highly informative compound nucleotide repeat in the neurofibromatosis (NF1) gene. Hum Mol Genet 2:1083, 1993
37. Lazaro C, Gaona A, Estivill X: Two CA/GT repeat polymorphisms in intron 27 of the human NF1 gene. Hum Genet 93:351, 1994
38. Birnbaum R, O'Marcaigh A, Wardak Z, Zhang Y, Dranoff G, Jacks T, Clapp DW, Shannon KM: Interaction between NF1 and GMCSF in leukemogenesis and hematopoietic engraftment. Blood 90:411 a, 1997 (abstr, suppl 1)
39. Mahgoub N, Taylor B, Le Beau M, Gratiot M, Carlson K, Jacks T, Shannon KM: A mouse model of alkylator-induced leukemia. Blood 90:385a, 1997 (abstr, suppl 1)
40. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307, 1994
41. Sawyers CL, Denny CT: Chronic myelomonocytic leukemia: Tel-a-kinase what ets all about. Cell 77:171, 1994
42. Boguski M, McCormick F: Proteins regulating Ras and its relatives. Nature 366:643, 1993
43. Friedman E, Gejman P, Martin G, McCormick F: Nonsense mutations in the C-terminal SH2 region of the GTPase activating protein (GAP) gene in human tumours. Nat Genet 5:242, 1993
44. Friedman E: The role of ras GTPase activating protein in human tumorigenesis. Pathobiology 63:348, 1995
45. Henkemeyer M, Rossi D, Holmyard D, Puri M, Mbamalu G, Harpal K, Shih TS, Jacks T, Pawson T: Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase activating protein. Nature 377:695, 1995
46. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS: Seletive hypersensitivity to granulocyte-macrophage colony stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 77:925, 1991
47. Freeburn R, Gale R, Wagner H, Linch D: Analysis of the coding sequence for the GM-CSF receptor α and β chains in patients with juvenile chronic myeloid leukemia (JCML). Exp Hemat 25:306, 1997
48. Snyder RC, Wiley T, Castleberry RP, Emanuel PD: Increased levels of the p85α subunit of phosphatidylinositol 3-OH kinase in cell lysates of juvenile myelomonocytic leukemia cells. Blood 90:411a, 1997 (abstr, suppl 1)
49. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J: Phosphatidylinositol3-OH kinase as a direct target of Ras. Nature 370:527, 1994
50. Xu W, Mulligan L, Ponder MA, Liu L, Smith BA, Mathew CG, Ponder BA: Loss of alleles in pheochromocytomas from patients with type 1 neurofibromatosis. Genes Chromosomes Cancer 4:337, 1992
51. Skuse GR, Kosciolek BA, Rowley PT: Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer 1:36, 1989
52. Menon AG, Anderson KM, Riccardi VM, Chung RY, Whaley JM, Yandell DW, Farmer GE, Freiman RN, Lee JK, Li FP, Barker DF, Ledbetter DH, Kleider A, Martuza RL, Gusella JF, Seizinger BR: Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 87:5435, 1990
53. Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K, Friedman E, Samowitz W, Robertson M, Bradley P, McCormick F, White R, Cawthon R: Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69:275, 1992